What Makes a Good Biomarker?

Time: 8:30 am
day: Day Two Morning

Details:

• Millions are spent on biomarker research in academia and industry but only a tiny fraction, less than 2%, achieve clinical adoption with the rest stalling or failing
• This talk will consider where we are failing in biomarker research and how academia and industry can work better together to discover, validate and implement the biomarkers we need to improve patient care
• It will also consider what features of biomarkers make them most likely to succeed

Speakers: